Syngenta today acknowledged that European Union (EU) Member States for the second time failed to agree on the European Commission’s proposal for a ban on neonicotinoid pesticides. The latest decision should compel the Commission to return to the negotiating table rather than forcing through the implementation of a ban.
Syngenta Chief Operating Officer, John Atkin, said: “The European Commission has again failed to win the necessary support for its proposed ban on this vital technology. The proposal is based on poor science and ignores a wealth of evidence from the field that these pesticides do not damage the health of bees. Instead of banning these products, the Commission should now take the opportunity to address the real reasons for bee health decline: disease, viruses and loss of habitat and nutrition.”
The proposed ban was triggered by a hurried and highly theoretical review by the European Food Safety Agency (EFSA). It made fundamental mistakes including a serious over-estimation of the amount of pesticide bees are exposed to in the field. It also ignored key studies and independent monitoring, including recent data from the UK Government, which found no evidence that neonicotinoids impact bee health.
Bee health decline is among the biggest challenges facing agriculture. Syngenta again called on the European Commission to broaden efforts to tackle the real causes of bee health decline. The company highlighted the recent launch of its own bee health action plan, which complements its work over the past 10 years through the Operation Pollinator initiative.
Syngenta is one of the world's leading companies with more than 27,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life. For more information about us please go to www.syngenta.com.
Cautionary Statement Regarding Forward-Looking Statements
This document contains forward-looking statements, which can be identified by terminology such as ‘expect’, ‘would’, ‘will’, ‘potential’, ‘plans’, ‘prospects’, ‘estimated’, ‘aiming’, ‘on track’ and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefor.